News

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Introduction to the Class Action Lawsuit

Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial financial losses from your investments in Sage, now is the time to consider your options.

Who is Affected by This Lawsuit?

This class action lawsuit targets all individuals and entities who purchased or acquired shares of Sage Therapeutics securities during a specified period. This period runs from April 12, 2021, to July 23, 2024, marking the time when significant events and discrepancies in the company's disclosures may have caused harm to investors.

Understanding the Allegations

The crux of the lawsuit revolves around the assertion that the officials at Sage made materially false and misleading statements regarding the company's operations and its financial health. The claims suggest that these misleading communications distorted the true effectiveness of Sage's main treatments:

Key Treatment Misrepresentations

Throughout the aforementioned period, the lawsuit alleges that Defendants consistently conveyed unwarranted optimism about their products:

  • The effectiveness of zuranolone in treating Major Depressive Disorder (MDD) was overstated, undermining FDA approval prospects.
  • SAGE-718 was suggested to possess greater efficacy for Mild Cognitive Impairment (MCI) than may actually be the case.
  • SAGE-324's capacity to treat Essential Tremor (ET) was also claimed to be more effective than what the clinical data suggested.

All these assertions led investors to hold a false sense of security about the commercial viability of these treatments, impacting their investment decisions significantly.

Steps Forward for Investors

Now that a class action has been initiated, affected investors can take measures to potentially recover their losses. If you would like to obtain more details about the legal complaint or to assess your individual situation, resources are available through Bronstein, Gewirtz & Grossman. They can provide necessary documents and guidance regarding the case.

Contacting the Legal Firm

For those interested in pursuing legal action, contacting Peretz Bronstein or Nathan Miller at Bronstein, Gewirtz & Grossman, LLC could be an essential step. The firm's dedicated team can guide you through the processes involved in filing your claim before the upcoming deadline.

Contingency-Based Representation

One reassuring fact about this representation is that it operates on a contingency fee basis, which means no upfront fees for you. The firm's compensation comes from any successful recovery, reassuring investors that their interests come first in this legal journey.

Why Choose Bronstein, Gewirtz & Grossman?

This firm has built a solid reputation over the years, addressing securities fraud claims and representing investors in other significant legal matters. Achieving hundreds of millions in recovery for investors sets a testament to their expertise and dedication. They understand the importance of transparency and client-focused service during these challenging times.

Frequently Asked Questions

What is the purpose of the class action lawsuit against Sage Therapeutics?

The lawsuit aims to recover damages for investors who suffered losses due to misleading statements made by the company regarding its products and their effectiveness.

Who can join the class action lawsuit?

All individuals or entities who purchased Sage Therapeutics securities between April 12, 2021, and July 23, 2024, can potentially join the lawsuit.

How can I get involved in the lawsuit?

Interested parties should contact Bronstein, Gewirtz & Grossman, LLC to explore their options for becoming part of the legal action.

Is there any cost to participate in the class action?

No, this representation operates on a contingency fee basis, meaning you won’t pay unless the firm successfully recovers funds on your behalf.

What should I do if I have more questions?

You can reach out to the firm directly for insights and detailed answers regarding your specific situation and potential involvement in the lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 44

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 148

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 134

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 64

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 124

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 120

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 122

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 270

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 102

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading

Top 5 Most Recently Viewed Articles

Starbucks Earnings Anticipation: Growth and Challenges Ahead

Updated Category News Views 152

Starbucks Earnings Preview Starbucks (NASDAQ: SBUX) is set to announce its quarterly earnings shortly. Investors are keenly awaiting the report, reflecting hopes for positive outcomes and growth perspectives. The anticipation surrounding this announcement includes significant insights that could shape investor sentiment. Expected Earnings Report Analysts have projected...

Continue Reading
Understanding the Current Options Trends of T-Mobile US

Updated Category News Views 192

Insights into T-Mobile US Options Activity Recently, T-Mobile US has witnessed a stark shift in options trading, driven by significant market movements. A detailed examination of the options history for T-Mobile US (NASDAQ: TMUS) has unveiled a string of unusual trades that indicate a complex trading atmosphere. Delving deeper, our analysis shows that about 41% of traders...

Continue Reading
Arteris, Inc. Boosts Team with New Inducement Stock Awards

Updated Category News Views 282

Arteris, Inc. Announces Substantial Inducement Stock Grants Arteris, Inc. (Nasdaq: AIP), a prominent provider of system IP for accelerating semiconductor innovation, recently revealed an exciting development regarding its workforce expansion. The company has made the decision to grant a total of 109,000 restricted stock units (RSUs) to four newly hired employees as part...

Continue Reading
Enhanced Drill Insights from Freeman Gold's Latest Project

Updated Category News Views 217

Freeman Gold Unveils Significant Drill Results Freeman Gold Corp. (TSXV: FMAN, OTCQB: FMANF) has recently shared exciting outcomes from its expanded drilling initiative, which aims to enhance the Lemhi Gold Project. The results of the three drill holes from the southern segment of their 2025 drilling program indicate potential for substantial gold deposits, further...

Continue Reading
Exploring the Growth of the Paper and Paperboard Market

Updated Category News Views 146

Forecasting the Future of Paper and Paperboard Packaging The global paper and paperboard container and packaging market is on track to experience remarkable growth, with estimated revenues soaring by USD 59.15 billion during the forecast period. The projected CAGR for this timeframe stands at 4.39%, fueled by a surge in the demand for specialized containers and innovative...

Continue Reading